Embla Medical hf (OSSFF)
4.525
0.00 (0.00%)
USD |
OTCM |
Oct 13, 16:00
Embla Medical hf Gross Profit Margin (Quarterly) : 59.26% for June 30, 2026
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 59.26% |
| March 31, 2026 | 56.96% |
| December 31, 2025 | 57.83% |
| September 30, 2025 | 58.21% |
| June 30, 2025 | 58.10% |
| March 31, 2025 | 58.67% |
| December 31, 2024 | 59.18% |
| September 30, 2024 | 58.66% |
| June 30, 2024 | 59.97% |
| March 31, 2024 | 56.04% |
| December 31, 2023 | 57.47% |
| September 30, 2023 | 57.77% |
| June 30, 2023 | 58.63% |
| March 31, 2023 | 57.52% |
| December 31, 2022 | 56.45% |
| September 30, 2022 | 56.94% |
| June 30, 2022 | 57.02% |
| March 31, 2022 | 56.67% |
| December 31, 2021 | 58.85% |
| September 30, 2021 | 57.33% |
| June 30, 2021 | 59.20% |
| March 31, 2021 | 58.98% |
| December 31, 2020 | 59.32% |
| September 30, 2020 | 58.49% |
| June 30, 2020 | 43.16% |
| Date | Value |
|---|---|
| March 31, 2020 | 57.86% |
| December 31, 2019 | 58.40% |
| September 30, 2019 | 60.55% |
| June 30, 2019 | 60.75% |
| March 31, 2019 | 60.43% |
| December 31, 2018 | 61.21% |
| September 30, 2018 | 61.33% |
| June 30, 2018 | 60.53% |
| March 31, 2018 | 60.21% |
| December 31, 2017 | 60.78% |
| September 30, 2017 | 60.41% |
| June 30, 2017 | 59.34% |
| March 31, 2017 | 59.92% |
| December 31, 2016 | 60.23% |
| September 30, 2016 | 60.38% |
| June 30, 2016 | 61.99% |
| March 31, 2016 | 60.08% |
| December 31, 2015 | 59.70% |
| September 30, 2015 | 60.26% |
| June 30, 2015 | 60.76% |
| March 31, 2015 | 60.20% |
| December 31, 2014 | 60.69% |
| September 30, 2014 | 61.89% |
| June 30, 2014 | 61.79% |
| March 31, 2014 | 60.10% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Enovis Corp. | 54.51% |
| Edwards Lifesciences Corp. | 78.09% |
| Intuitive Surgical, Inc. | 67.76% |
| Kewaunee Scientific Corp. | 29.61% |
| STAAR Surgical Co. | 71.98% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 10.64% |
| Return on Assets | 5.50% |
| Return on Invested Capital | 6.56% |
| Profit Margin (Quarterly) | 11.34% |
| Operating Margin (Quarterly) | 16.10% |
| Return on Net Operating Assets | 6.37% |